Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with GENB: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
GENB
Generate Biomedicines, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
GENB
Generate Biomedicines, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
GENB, dashed
LLY
ELI Lilly & Co
Change
1,371.32
· pre 1,342.99
· delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
GENB
Generate Biomedicines, Inc.
Change
12.73
· pre 13.42
· delayed
Pre-market
Nov 6 '26
delayed
Mkt cap
$1.6B
Revenue
$6M
Q2 FY26
Revenue
—
vs
Compare
Pre-market
Nov 6 '26
delayed
LLY
ELI Lilly & Co
vs
GENB
Generate Biomedicines, Inc.
1,371.32
pre 1,342.99
delayed
Price
12.73
pre 13.42
delayed
$1.2T
Mkt cap
$1.6B
Q3 FY26
$24.4B
Revenue
$6M
Q2 FY26
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,371.32
vs
GENB
12.73
Pre-market
Nov 6 '26
delayed